Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duke University
With
University of Michigan
Emory Healthcare
Johns Hopkins University
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
Morehouse School of Medicine
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed diagnosis of prostate adenocarcinoma
Age ≥18 years
Receiving curative intent radiotherapy for prostate cancer (Note: post-operative radiotherapy \[i.e., "adjuvant" or "salvage radiotherapy subsequent to prostatectomy\] is allowed.)
Subjects will be enrolled within two weeks prior to and two weeks after the final fraction of radiotherapy.
Receiving androgen deprivation therapy (ADT) for a duration of ≥3 consecutive months as follows:
* GnRH agonist or antagonist (medical castration), with or without an anti-androgen (i.e., bicalutamide, flutamide, nilutamide, etc.), OR
* Bilateral orchiectomy (surgical castration)
Technology requirement: candidates must have access to the internet
Able to understand and willing to sign a written informed consent document.
Able to speak and understand English, in the opinion of the treating physician.
You may not be if
Significant concurrent medical or psychiatric condition that would interfere with the patient's ability to abide by the study protocol or cooperate fully with the protocol requirements, including completion of survey and assessment
Clareo Health | A Survivorship Care Plan and Embedded Navigation Tool
